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Edited by Christian GriesingerAbstract The agouti signaling protein (ASIP) and its homolog,
the agouti-related protein (AgRP), act as inverse agonists that
control, respectively, pigmentation and metabolic function in
mammals. NMR investigations ﬁnd that the C-terminal domains
of these proteins adopt a fold consistent with an inhibitor cystine
knot (ICK), previously identiﬁed in invertebrate toxins. Although
these structural studies suggest that ASIP and AgRP deﬁne a
new mammalian protein fold class, the results with ASIP are
inconclusive. Here, we apply direct chemical mapping to deter-
mine the complete set of disulﬁde linkages in ASIP. The results
demonstrate unequivocally that ASIP adopts the ICK fold and
thereby supports a recent evolution structure function analysis,
which proposes that ASIP and AgRP arose from a common
antagonist ligand.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Binding of the agouti signaling protein (ASIP) to the mela-
nocortin-1 receptor (MC1R) in the skin results in production
of the yellow/red pigment pheomelanin [1,2]. Mice with the
agouti lethal yellow mutation (Ay/a) express ASIP ubiqui-
tously, and the interaction of ASIP with the MC4 receptor
in the hypothalamus causes obesity and metabolic characteris-
tics associated with type II diabetes, including insulin and lep-
tin resistance [3].
There are several unique and important aspects of ASIP’s
structure and biochemical behavior. First, melanocortin recep-
tors (MCRs) are members of the G-protein coupled receptor
(GPCR) family and ASIP, along with its homolog the agou-
ti-related protein (AgRP), which is normally expressed in the
brain, are the only known endogenous GPCR antagonists
(or inverse agonists); both ASIP and AgRP act to block the ac-
tion of the agonist a-MSH (reviewed in Ref. [4]). Second,
whereas many GPCR ligands are small, easily diﬀusible pep-Abbreviations: ASIP, agouti signaling protein; MCR, melanocortin
receptor; TCEP, tris(2-carboxyethyl)phosphine; NEM, N-ethylmalei-
mide
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doi:10.1016/j.febslet.2007.10.062tides or low molecular weight species, ASIP is a 110 residue
(after removal of the signal peptide) glycoprotein with a
folded, cysteine-rich C-terminal domain [5]. Third, because
of the hyperphagia and metabolic characteristics associated
with Ay/a mice, these animals, and those with similar muta-
tions, are widely used as obesity models [1].
ASIP’s forty residue, Cys-rich, C-terminal domain alone
contains the determinants for high aﬃnity binding to MC1/
4R [6,7]. Structural studies of this domain identify yet another
potentially unique ASIP feature – the 10 cysteines are thought
to form a network of ﬁve disulﬁde bonds arranged in an inhib-
itor cystine knot (ICK), or knottin, fold motif previously
found in invertebrate toxins [6,8,9]. Characterization of this
fold in the homolog AgRP is now well established by both
chemical mapping [10] and NMR structural studies [11].
The speciﬁc fold of ASIP, however, is less clear. NMR stud-
ies on ASIP(80–132) by our lab identiﬁed a low energy back-
bone conformation quite similar to that of AgRP and
consistent with the ICK motif [6]. But studies on structurally
related toxins demonstrate that backbone fold alone is insuﬃ-
cient to deﬁne ICK disulﬁde bond pairings (e.g., Ref. [12]).
NMR contacts in ASIP unambiguously identiﬁed disulﬁde
bonds Cys93–Cys108, Cys116–Cys123 and Cys111–Cys132
by NOEs between speciﬁc side-chain b protons [6]. However,
Cys side-chains 100, 107, 114 and 125 are all in near proximity
thus confounding direct disulﬁde assignment by visual inspec-
tion or by side chain NOEs. The situation is further compli-
cated by cis/trans isomerization of the Ala104–Pro105 imide
backbone bond, which gives two distinct orientations of the
ASIP(80–132) N-terminal loop, and structural heterogeneity
for residues 100–106. Oftentimes energy calculations provide
a reliable means for identifying the correct disulﬁde network.
Speciﬁcally, DYANA calculations performed on all possible
disulﬁde arrangements give the lowest target function only
for the backbone conformation with the correct linkages
[13]. This approach was attempted with ASIP and, unfortu-
nately, failed to clearly identify a unique low energy fold,
applicable to both cis and trans conformations [6].
A recent study using Evolution Structure Function analysis
suggests that AgRP and ASIP arose from a common antago-
nist ligand that originally served to control both pigmentation
and energy balance as a means for adapting to starvation [14].
In light of this proposal, and the fundamental structural issues
discussed above, elucidating the exact ASIP fold is vital for
establishing whether indeed AgRP and ASIP comprise a un-
ique motif newly identiﬁed in mammals. To address these is-
sues, we apply direct chemical mapping to determine the
exact disulﬁde arrangement in ASIP. The method employsblished by Elsevier B.V. All rights reserved.
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forms of ASIP, followed by trypsin digestion and tandem
MS sequencing. These data, in conjunction with the recently
determined NMR structure, provide an unequivocal classiﬁca-
tion of the ASIP fold.0.5
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H2. Materials and methods
2.1. Solid phase protein synthesis
In previous work, C-terminal ASIP was prepared as two separate
strands, which were then linked by native chemical ligation [6]. For
these current studies, ASIP(80-132, Q115Y, S124Y), referred to as
ASIP-YY, was prepared as a single strand using an Applied Biosys-
tems 433A synthesizer and standard Fmoc chemistry. Fmoc-
Cys(Trt)-OPfp was used to avoid enantiomerization of the a-carbon.
Puriﬁcation and oxidative folding followed the exact same procedures
described previously [6].0
15 20 25 30
Time (minutes)
Fig. 1. HPLC trace of partially reduced ASIP-YY. The number of free
–SH groups in each fraction is labeled and was determined by reaction
with NEM, followed by mass analysis.2.2. Partial reduction and alkylation of nascent cysteine residues
Partial reduction was initiated by introducing ASIP-YY (1.0 mM)
into a pH 3 solution containing 40 mM tris(2-carboxyethyl)phosphine
(TCEP) and 100 mM sodium citrate [15]. After 20 min the solution was
diluted with distilled water and injected into an HPLC ﬁtted with a
C18 column (Alltech’s Alltima). Each partially reduced fraction was
collected and lyophilized overnight for future usage. In partially
reduced fractions, nascent cysteines were alkylated with N-ethylmalei-
mide (NEM) using a pH 3 solution of 100 mM NEM and 100 mM
sodium citrate. The reaction time was typically 20 min. Products were
repuriﬁed by HPLC.2.3. Trypsin digestion and analysis by mass spectrometry
Samples were ﬁrst treated dithiothreitol (DTT) to eliminate any
remaining disulﬁde bonds. Speciﬁcally, peptides were treated for 2 h
with 5 mM DTT, 6.0 M guanidine hydrochloride (GuHCl) in 100 mM
2-amino-2-hydroxymethyl-1,3-propanediol (Tris) solution at pH 8.
Next, a 50 mMNH4HCO3 solution was added to dilute theGuHCl con-
centration to less than 1 M. Trypsin digestion used reagents and proce-
dures from Promega. Trypsin was used in a protease to protein ratio of
1:20 and incubated at 37 C for 4 h. The mixture was diluted with dis-
tilled water and puriﬁed by HPLC using a C18 column. Each fraction
was collected for mass and sequence analysis. Mass spectrometry was
performed using either a Micromass ZMD 4000 or a Thermo Finnigan
LTQ. MSn experiments were performed with the LTQ.3. Results and discussion
3.1. Disulﬁde mapping
Chemical disulﬁde mapping was performed on the stable
double mutant ASIP(80–132, Q115Y, S124Y), referred to as
ASIP-YY [6]. Under oxidizing conditions, ASIP-YY folds to
a uniform product, as determined by both HPLC and MS,
and is fully active at the MC1/3/4 receptors, with the same po-
tency as the wild-type protein [6]. TCEP was used to gently and
selectively reduce disulﬁde bonds [10,15]. Reduction at acidic
pH avoids disulﬁde rearrangement. Partially reduced species
were then separated by HPLC. Next, treatment of each sepa-
rated species with the alkylating agent NEM labeled the free
sulfhydryl groups, and this was followed by complete reduc-
tion using DTT. The selectively labeled peptides were sub-
jected to trypsin proteolysis, which cleaves after basic
residues (primarily Arg in ASIP), and the resulting fragments
were sequenced by tandem MS to locate each NEM labeled
thiol group.
Fig. 1 shows an HPLC trace following treatment with
TCEP. Peaks b–h correspond to distinct partially reducedspecies. Starting with peak b, mass analysis of the NEM re-
acted product shows that this species contained two free sulf-
hydryl groups. Trypsin treatment, followed by MS analysis
of the resulting fragments showed that the peptides ASIP-
YY(98–117) and ASIP-YY(127–132) each contained a single
NEM modiﬁcation. The latter of these two peptides contains
only a single Cys, thus locating one of the disulﬁde bond part-
ners to Cys132. By contrast, ASIP-YY(98–117) contains six
Cys, thus requiring direct sequencing to locate the modiﬁed
residue.
MS/MS of singly NEM modiﬁed ASIP-YY(98–117) from
peak b, shown in Fig. 2A, reveals a progression of signals con-
sistent with a loss of single amino acids cleaved at the peptide
bond. Typical of trypsin digests, y ions are enhanced due to the
positively charged residue at their C-termini. Sequencing from
the N-terminus through residue 109 showed that the modiﬁed
Cys resided in the segments 110–117. Further fragmentation
was not observed so the ASIP-YY(110–117) y8-ion
(1027.18 amu) was maintained in the MS trap for further
MS/MS/MS analysis, as shown in Fig. 2B. Following loss of
N-terminal Pro110, sequential fragmentation of the y7-ion
gave a change in mass from 930.33 amu to 702.30 amu, corre-
sponding to an NEMmodiﬁed cysteine, thus locating the other
disulﬁde bond partner to Cys111. Loss of additional amino
acids was consistent with y-ion fragmentation of the unmodi-
ﬁed peptide ASCYCR. Taken together, these data demon-
strate that ASIP-YY contains a disulﬁde bond between
Cys111 and Cys132, as found in the NMR structure.
HPLC peaks c, e, g and h, with four, six, eight and eight
NEM modiﬁcations, respectively, were subjected to the same
digestion and MS analysis, thus locating all pairwise NEM
labeled Cys residues. Peaks d and f were heterogeneous and
therefore not used in our analysis. The results are summarized
in Fig. 3. Here, Cys residues colored with a blue back-
ground identify NEM labeling. The vertical red lines indicate
observed trypsin cleavage sites. Peak c revealed four NEM
modiﬁcations; two conﬁrmed labeling at Cys111 and Cys132
Fig. 2. Example MS sequencing: trypsin fragment ASIP-YY(98–117) from peak b. (A) MS/MS gives the expected sequence from Pro102 and
demonstrates that Cys107 and Cys108 are not modiﬁed by NEM. (B) MS/MS/MS of the y8-ion shows that Cys111 is NEMmodiﬁed and thus forms a
disulﬁde bond with Cys132. Several b-ions and other MS peaks are identiﬁed.
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with comparison to peak b, a new disulﬁde bond is identiﬁed
between Cys116–Cys123. Similarly, peak e builds on the previ-
ous results and ﬁnds a disulﬁde bond between Cys100–Cys114
and peak g identiﬁes disulﬁde bond Cys93–Cys108. Peak h is
complementary to g and reveals NEM modiﬁcations that lo-
cate the ﬁnal disulﬁde bond between Cys107 and Cys125, con-
sistent with the unmodiﬁed cysteines in peak g, and vice versa.For all peaks, the results were unambiguous – there was no evi-
dence of alternate NEM labeling or disulﬁde connectivities
inconsistent with those reported in Fig. 3.
3.2. Disulﬁde bonds and characterization of the ICK Fold
The resulting network of disulﬁde bonds is diagrammed
underneath the sequences in Fig. 3. The connectivities are sup-
ported by a previously reported partial chemical analysis by
Fig. 3. Summary of NEM modiﬁcations in each of the HPLC peaks. Vertical red lines indicate trypsin cleavage sites and Cys residues with a blue
background identify NEM modiﬁcations. Peak b contains two modiﬁcations thus identifying the Cys111–Cys132 disulﬁde. Peak c contains two
additional modiﬁcations demonstrating linkage between Cys116–Cys123, and so forth. The resulting disulﬁde linkage map is shown below the
sequences. The thin lines are consistent with disulﬁdes identiﬁed in the NMR structure; the thick lines are newly identiﬁed by chemical mapping here.
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that located N– vs C– disulﬁde bond partners [7]. The thin
lines in Fig. 3 represent those disulﬁde bonds that were
unequivocally mapped by NMR. The thick lines are newly
identiﬁed here and essential for determining whether ASIP be-
longs in the ICK fold class. Fig. 4 shows the NMR structure of
ASIP-YY [6]. Disulﬁde bonds found by NMR and conﬁrmed
here are yellow and the new disulﬁde bonds found by chemical
mapping are green. Examination of the ASIP-YY structure re-
veals a topological circle formed by peptide segments 93–100
and 108–114, connected by disulﬁde bonds Cys93–Cys108
and Cys100–Cys114. Disulﬁde bond Cys107–Cys125 threads
from the front of the protein to the back through this topolog-
ical circle, a deﬁning feature of the ICK fold motif [8,9,16,17].
Homology models based on known toxin structures previ-
ously suggested that agouti and AGRP would adopt a toxin-
like ICK fold [18]. Although such predictions seem reasonable
by the criteria of homology models, the suggestion of a toxin
fold for AGRP or ASIP was nevertheless remarkable since this
fold type had never been observed in mammalian proteins.
Over the last few years, the assignment of AgRP to the ICK
fold has been conclusively demonstrated, both by chemical
mapping and NMR. The ASIP sequence contains the appro-Fig. 4. Structure of ASIP-YY showing the complete disulﬁde map.
The yellow colored disulﬁde bonds are consistent with those identiﬁed
in the NMR structure; the green bonds are identiﬁed here by chemical
mapping here. The disulﬁde bond from Cys107 to Cys125 threads from
the front to the back of the protein and demonstrates unequivocally
that ASIP is a member of the inhibitor cystine knot family.priate cysteine spacing and the backbone geometry determined
by NMR is consistent with an ICK fold. Our chemical map-
ping here demonstrates conclusively that ASIP indeed pos-
sesses the ICK disulﬁde links and, along with AgRP, deﬁnes
a fundamentally new fold class for mammalian proteins.
The N-terminal domains of ASIP and AgRP exhibit little
sequence homology. Moreover, recent studies clearly demon-
strate they possess distinct physiological functions. The N-
terminal domain of ASIP binds to the transmembrane protein
Attractin, and this interaction is required for ASIP signaling
in vivo [19]. In contrast, very recent work shows that the N-ter-
minal domain of AgRP is actually a prodomain, the removal
of which is required for high aﬃnity MC4 receptor antagonism
[14,20]. There are also fundamental sequence diﬀerences be-
tween the ASIP and AgRP Cys-rich C-terminal domains.
The loops spanning the ﬁnal two Cys residues (the so-called
C-terminal loops) are diﬀerent in length and only ASIP con-
tains the distinct proline rich segment between the second
and third Cys residues. Despite these diﬀerences, orthologs
of both ASIP and AgRP, now found in a variety of lower ver-
tebrates including ﬁsh, exhibit very similar intron–exon struc-
tures [6,21]. Phylogenetic analysis argues that ASIP and AgRP
share a common ancestor that arose early in vertebrate evolu-
tion [14]. Although there are numerous sequence diﬀerences
between ASIP and AgRP, as described above, our work shows
that both proteins have identical C-terminal ICK disulﬁde
crosslinks with superimposable backbone folds thus deﬁning
a new and unique mammalian fold motif.Acknowledgements: This work was supported by Grants from the Na-
tional Institutes of Health (DK064265 to G.L.M and RR020939 in
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